Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Drug-eluting stent restenosis: an uncommon yet pervasive problem.

Teirstein PS.

Circulation. 2010 Jul 6;122(1):5-7. doi: 10.1161/CIRCULATIONAHA.110.962423. Epub 2010 Jun 21. No abstract available.

2.

Outcomes following coronary stenting in the era of bare-metal vs the era of drug-eluting stents.

Malenka DJ, Kaplan AV, Lucas FL, Sharp SM, Skinner JS.

JAMA. 2008 Jun 25;299(24):2868-76. doi: 10.1001/jama.299.24.2868.

3.

ESC Forum on Drug Eluting Stents European Heart House, Nice, 27-28 September 2007.

Daemen J, Simoons ML, Wijns W, Bagust A, Bos G, Bowen JM, Braunwald E, Camenzind E, Chevalier B, Dimario C, Fajadet J, Gitt A, Guagliumi G, Hillege HL, James S, Jüni P, Kastrati A, Kloth S, Kristensen SD, Krucoff M, Legrand V, Pfisterer M, Rothman M, Serruys PW, Silber S, Steg PG, Tariah I, Wallentin L, Windecker SW, Aimonetti A, Allocco D, Baczynska A, Bagust A, Berenger M, Bos G, Boam A, Bowen JM, Braunwald E, Calle JP, Camenzind E, Campo G, Carlier S, Chevalier B, Daemen J, de Schepper J, Di Bisceglie G, Dimario C, Dobbels H, Fajadet J, Farb A, Ghislain JC, Gitt A, Guagliumi G, Hellbardt S, Hillege HL, Ten Hoedt R, Isaia C, James S, de Jong P, Jüni P, Kastrati A, Klasen E, Kloth S, Kristensen SD, Krucoff M, Legrand V, Lekehal M, Lenarz L, Ni Mhullain F, Nagai H, Patteet A, Paunovic D, Pfisterer M, Potgieter A, Purdy I, Raveau-Landon C, Rothman M, Serruys PW, Silber S, Simoons ML, Steg PG, Tariah I, Ternstrom S, Van Wuytswinkel J, Waliszewski M, Wallentin L, Wijns W, Windecker SW.

Eur Heart J. 2009 Jan;30(2):152-61. doi: 10.1093/eurheartj/ehn510. Epub 2008 Nov 26. No abstract available.

4.

A randomized, double-blind, multicenter comparison study of triple antiplatelet therapy with dual antiplatelet therapy to reduce restenosis after drug-eluting stent implantation in long coronary lesions: results from the DECLARE-LONG II (Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients with Long Coronary Lesions) trial.

Lee SW, Park SW, Kim YH, Yun SC, Park DW, Lee CW, Kang SJ, Park SJ, Lee JH, Choi SW, Seong IW, Lee NH, Cho YH, Shin WY, Lee SJ, Lee SW, Hyon MS, Bang DW, Choi YJ, Kim HS, Lee BK, Lee K, Park HK, Park CB, Lee SG, Kim MK, Park KH, Park WJ; DECLARE-LONG II Study Investigators.

J Am Coll Cardiol. 2011 Mar 15;57(11):1264-70. doi: 10.1016/j.jacc.2010.10.035.

5.

Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction.

Dangas GD, Caixeta A, Mehran R, Parise H, Lansky AJ, Cristea E, Brodie BR, Witzenbichler B, Guagliumi G, Peruga JZ, Dudek D, Möeckel M, Stone GW; Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial Investigators.

Circulation. 2011 Apr 26;123(16):1745-56. doi: 10.1161/CIRCULATIONAHA.110.981688. Epub 2011 Apr 11.

6.

Drug-eluting stents: issues of late stent thrombosis.

Lemesle G, Maluenda G, Collins SD, Waksman R.

Cardiol Clin. 2010 Feb;28(1):97-105. doi: 10.1016/j.ccl.2009.09.003. Review.

PMID:
19962052
7.

Management of drug-eluting stent restenosis.

Ishikawa K, Aoyama Y, Hirayama H.

J Invasive Cardiol. 2012 Apr;24(4):178-82. Review.

8.

Drug-eluting coronary stents: many meta-analyses, little benefit.

[No authors listed]

Prescrire Int. 2009 Apr;18(100):70-4.

PMID:
19585727
9.

Long-term safety and efficacy of drug-eluting versus bare-metal stents in Sweden.

James SK, Stenestrand U, Lindbäck J, Carlsson J, Scherstén F, Nilsson T, Wallentin L, Lagerqvist B; SCAAR Study Group.

N Engl J Med. 2009 May 7;360(19):1933-45. doi: 10.1056/NEJMoa0809902.

10.

Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials.

Bangalore S, Kumar S, Fusaro M, Amoroso N, Attubato MJ, Feit F, Bhatt DL, Slater J.

Circulation. 2012 Jun 12;125(23):2873-91. doi: 10.1161/CIRCULATIONAHA.112.097014. Epub 2012 May 14.

11.

Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease.

Hannan EL, Wu C, Walford G, Culliford AT, Gold JP, Smith CR, Higgins RS, Carlson RE, Jones RH.

N Engl J Med. 2008 Jan 24;358(4):331-41. doi: 10.1056/NEJMoa071804.

12.

Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) study.

Mehilli J, Byrne RA, Tiroch K, Pinieck S, Schulz S, Kufner S, Massberg S, Laugwitz KL, Schömig A, Kastrati A; ISAR-DESIRE 2 Investigators.

J Am Coll Cardiol. 2010 Jun 15;55(24):2710-6. doi: 10.1016/j.jacc.2010.02.009. Epub 2010 Mar 11.

13.

Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction.

Stone GW, Lansky AJ, Pocock SJ, Gersh BJ, Dangas G, Wong SC, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Möckel M, Ochala A, Kellock A, Parise H, Mehran R; HORIZONS-AMI Trial Investigators.

N Engl J Med. 2009 May 7;360(19):1946-59. doi: 10.1056/NEJMoa0810116.

14.

In-stent restenosis.

Kim MS, Dean LS.

Cardiovasc Ther. 2011 Jun;29(3):190-8. doi: 10.1111/j.1755-5922.2010.00155.x. Epub 2010 Apr 9. Review.

PMID:
20406239
15.

Drug eluting stents for ST-elevation myocardial infarction: risk and benefit.

Ryan J, Cutlip DE, Cohen DJ, Pinto DS.

J Thromb Thrombolysis. 2007 Dec;24(3):293-9. Epub 2007 May 5. Review.

PMID:
17483875
16.

Clinical presentation and predictors of target vessel revascularization after drug-eluting stent implantation.

Al Muradi H, Mehra A, Okolo J, Vlachos H, Selzer F, Marroquin OC, Skelding K, Holper EM, Williams DO, Abbott JD.

Cardiovasc Revasc Med. 2012 Nov-Dec;13(6):311-5. doi: 10.1016/j.carrev.2012.10.003.

17.

Value and limitations of target-vessel ischemia in predicting late clinical events after drug-eluting stent implantation.

Zellweger MJ, Kaiser C, Brunner-La Rocca HP, Buser PT, Osswald S, Weiss P, Mueller-Brand J, Pfisterer ME; BASKET Investigators.

J Nucl Med. 2008 Apr;49(4):550-6. doi: 10.2967/jnumed.107.046771. Epub 2008 Mar 14.

18.

Elutax paclitaxel-eluting balloon followed by bare-metal stent compared with Xience V drug-eluting stent in the treatment of de novo coronary stenosis: a randomized trial.

Liistro F, Porto I, Angioli P, Grotti S, Ducci K, Falsini G, Bolognese L.

Am Heart J. 2013 Nov;166(5):920-6. doi: 10.1016/j.ahj.2013.08.023. Epub 2013 Oct 7.

PMID:
24176449
19.

Clinical characteristics of coronary drug-eluting stent fracture: insights from a two-center des registry.

Park KW, Park JJ, Chae IH, Seo JB, Yang HM, Lee HY, Kang HJ, Cho YS, Yeon TJ, Chung WY, Koo BK, Choi DJ, Oh BH, Park YB, Kim HS.

J Korean Med Sci. 2011 Jan;26(1):53-8. doi: 10.3346/jkms.2011.26.1.53. Epub 2010 Dec 22.

20.

Resistant in-stent restenosis in the drug eluting stent era.

Theodoropoulos K, Mennuni MG, Dangas GD, Meelu OA, Bansilal S, Baber U, Sartori S, Kovacic JC, Moreno PR, Sharma SK, Mehran R, Kini AS.

Catheter Cardiovasc Interv. 2016 Nov;88(5):777-785. doi: 10.1002/ccd.26559. Epub 2016 May 17.

PMID:
27184223

Supplemental Content

Support Center